Tenaya Therapeutics (TNYA) stock plummets after disappointing results from Phase 1b/2 clinical trial for its gene therapy TN-201
https://seekingalpha.com/news/4387351-tenaya-stock-selloff-gene-therapy-data
Tenaya Therapeutics (TNYA) stock plummets after disappointing results from Phase 1b/2 clinical trial for its gene therapy TN-201
https://seekingalpha.com/news/4387351-tenaya-stock-selloff-gene-therapy-data
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.